JP2008501741A5 - - Google Patents

Download PDF

Info

Publication number
JP2008501741A5
JP2008501741A5 JP2007526245A JP2007526245A JP2008501741A5 JP 2008501741 A5 JP2008501741 A5 JP 2008501741A5 JP 2007526245 A JP2007526245 A JP 2007526245A JP 2007526245 A JP2007526245 A JP 2007526245A JP 2008501741 A5 JP2008501741 A5 JP 2008501741A5
Authority
JP
Japan
Prior art keywords
methylphenidate
pellet
layer
buffer system
active layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007526245A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008501741A6 (ja
JP2008501741A (ja
Filing date
Publication date
Priority claimed from ES200401412A external-priority patent/ES2261006B1/es
Application filed filed Critical
Publication of JP2008501741A publication Critical patent/JP2008501741A/ja
Publication of JP2008501741A6 publication Critical patent/JP2008501741A6/ja
Publication of JP2008501741A5 publication Critical patent/JP2008501741A5/ja
Withdrawn legal-status Critical Current

Links

JP2007526245A 2004-06-10 2005-06-01 多層制御放出性メチルフェニデートペレット Withdrawn JP2008501741A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200401412 2004-06-10
ES200401412A ES2261006B1 (es) 2004-06-10 2004-06-10 Pellet multicapa de liberacion controlada de metilfenidato.
PCT/EP2005/005874 WO2005120468A1 (en) 2004-06-10 2005-06-01 Multi-layered controlled-release methylphenidate pellet

Publications (3)

Publication Number Publication Date
JP2008501741A JP2008501741A (ja) 2008-01-24
JP2008501741A6 JP2008501741A6 (ja) 2008-05-29
JP2008501741A5 true JP2008501741A5 (enExample) 2008-07-10

Family

ID=34969228

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007526245A Withdrawn JP2008501741A (ja) 2004-06-10 2005-06-01 多層制御放出性メチルフェニデートペレット

Country Status (7)

Country Link
US (1) US20080069872A1 (enExample)
EP (1) EP1753410A1 (enExample)
JP (1) JP2008501741A (enExample)
CA (1) CA2566497A1 (enExample)
ES (1) ES2261006B1 (enExample)
IL (1) IL179338A0 (enExample)
WO (1) WO2005120468A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101288659B (zh) * 2007-04-18 2014-06-18 王雷波 一种胃内漂浮型微丸及其制备方法
EP2044932A1 (en) 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Mechanical protective layer for solid dosage forms
CN102238946B (zh) * 2008-11-07 2014-11-26 株式会社三养生物制药 用于哌醋甲酯的控制释放的药物组合物
JP5905872B2 (ja) * 2010-04-07 2016-04-20 ルピン・リミテッド タペンタドールの制御放出医薬組成物
MX2021000431A (es) * 2011-03-23 2022-10-28 Ironshore Pharmaceuticals & Dev Inc Metodos y composiciones para el tratamiento de trastorno por deficit de atencion.
KR101334947B1 (ko) * 2011-11-28 2013-11-29 이승우 서방성 정제 및 그 제조방법
ES2717469T3 (es) 2012-08-15 2019-06-21 Tris Pharma Inc Comprimido masticable de metilfenidato de liberación prolongada
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
TWI634909B (zh) * 2015-08-13 2018-09-11 生達化學製藥股份有限公司 Long-acting sustained-release medicine composition and preparation method thereof
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CN111557929B (zh) * 2020-05-15 2021-12-07 河南中帅医药科技股份有限公司 一种盐酸右哌甲酯多重释放制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
DE69920689T2 (de) * 1998-06-03 2005-02-24 Alza Corp., Mountain View Vorrichtungen zum Aufrechterhalten eines gewünschten therapeutischen Medikamenteneffekts über einen verlängerten Therapiezeitraum
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6562375B1 (en) * 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
US6344215B1 (en) 2000-10-27 2002-02-05 Eurand America, Inc. Methylphenidate modified release formulations

Similar Documents

Publication Publication Date Title
JP2008501741A5 (enExample)
HRP20171518T1 (hr) Tabletni pripravak bez prouzrokovanja kvarova kod tabletiranja
JP2003213038A5 (enExample)
JP2008513467A5 (enExample)
JP2010090168A5 (enExample)
JP2010529999A5 (enExample)
WO2008019871A3 (de) Neue salze des wirkstoffs rasagilin
WO2009038112A1 (ja) Ｎｐｙｙ５受容体拮抗剤を含有する固形製剤
WO2008114800A3 (en) Solid preparation comprising 2- [ [6- [ (3r) -3-amino-1-piperidinyl] -3, 4-dihydro-3-methyl-2, 4-dioxo-1 (2h) -pyrimidinyl] methyl] -4-fluorobenzonitrile
JP2013501762A5 (enExample)
HRP20171384T1 (hr) Farmaceutski pripravak
WO2009059701A3 (de) Retardtabletten mit hydromorphon
JP2011088913A5 (enExample)
HRP20110094T8 (en) Solid preparation comprising alogliptin and pioglitazone
WO2006114415A3 (de) Physiologisch verträgliche salze von 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
JP2005281687A5 (enExample)
JP2011519967A5 (enExample)
WO2008143240A1 (ja) 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法
WO2008008592A3 (en) Multi-particulate formulation having tramadol in immediate and controlled release form
JP2009517010A5 (enExample)
WO2007128478A3 (en) Pharmaceutical composition
MX2007008141A (es) Composicion farmaceutica de sustancias labiles en medio acido.
WO2007072495A3 (en) Coated tablets having prolonged gastric retention
DE602008000367D1 (de) Valsartanformulierungen
TR201906158T4 (tr) Etken Maddeler ile Farmasötik-Teknolojik Yardımcı Maddeler Arasındaki Etkileşimleri Engellemek Amacıyla Kullanılan Farmasötik Preparatlar İçin Ayırıcı Katmanlar.